Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A concise guide to retirement funds with the lowest fees, detailing how fees affect compounding and overall retirement outcomes.
26,827 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
IonQ stands at the crossroads of hype and real-world adoption in quantum computing. This ionq stock analysis: sell pi...
CrossCountry Mortgage appoints Raena Pinchuk as sales manager for Coeur d’Alene and the broader Pacific Northwest, ai...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
A Texas primary shock sends markets into a risk-off mode as sen. john cornyn becomes a flashpoint for party fault lin...
Investors are buzzing about SpaceX and a potential IPO that could push the company toward a $2 trillion valuation. Th...
CFO Mandy Fields shifts to lead e.l.f. Beauty's AI strategy, anchoring governance, commerce readiness and efficiency ...
In 2026, some AI-related players outshined Nvidia, delivering eye-popping gains and signaling a broader AI infrastruc...
A top AI analyst argues the AI revolution is still in its early stages, with ASML’s hefty backlog and robust Q1 2026 ...
This in depth review breaks down the lien 2026 earnings transcript in plain language. You’ll see what the numbers mea...
Hewlett Packard Enterprise just blew past expectations with stronger revenue and profits, stoking the AI server rally...
Stellantis is betting big on a single brand to lift profits in North America. This strategic move centers on Ram and ...